Efficacy and durability of two‐ vs . three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort-Reference-Cited by-同舟云学术

Efficacy and durability of two‐ vs . three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort

Published:2021-07-27 Issue:9 Volume:22 Page:843-853
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Fabbiani Massimiliano¹^ORCID,Rossetti Barbara¹^ORCID,Ciccullo Arturo²^ORCID,Oreni Letizia³,Lagi Filippo⁴,Celani Luigi⁵,Colafigli Manuela⁶,De Vito Andrea⁷^ORCID,Mazzitelli Maria⁸^ORCID,Dusina Alex²,Durante Miriam⁹,Montagnani Francesca¹⁹,Rusconi Stefano³^ORCID,Capetti Amedeo¹⁰,Sterrantino Gaetana⁴^ORCID,D’Ettorre Gabriella⁵,Di Giambenedetto Simona²,Zanelli Giacomo,Baldin Gianmaria,Borghetti Alberto,Latini Alessandra,Mastroianni Claudio,Borghi Vanni,Mussini Cristina,Cossu Maria Vittoria,Giacomelli Andrea,Formenti Tiziana,Trecarichi Enrico Maria,Torti Carlo,Madeddu Giordano,Vecchiet Jacopo,Vignale Francesca,Giacometti Andrea,

Affiliation:

1. UOC Malattie Infettive e TropicaliAzienda Ospedaliero‐Universitaria Senese Siena Italy

2. UOC Malattie InfettiveFondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

3. Infectious Diseases Unit DIBIC Luigi SaccoUniversity of Milan Milan Italy

4. Malattie Infettive e Tropicali Dipartimento di Medicina Clinica e Sperimentale Università di Firenze Firenze Italy

5. Department of Public Health and Infectious Diseases ‐ “Sapienza” University of Rome Rome Italy

6. Infectious Dermatology and Allergology Unit IFO S. Gallicano Institute (IRCCS) Rome Italy

7. Unit of Infectious Diseases Department of Medical Surgical and Experimental Sciences University of Sassari Sassari Italy

8. Infectious and Tropical Diseases Unit Department of Medical and Surgical Sciences Magna Graecia University Catanzaro Italy

9. Dipartimento di Biotecnologie Mediche Università degli Studi di Siena Siena Italy

10. Division of Infectious Diseases Department of Infectious Diseases Luigi Sacco University Hospital Milan Italy

Funder

ViiV Healthcare

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13146

Reference48 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Mortality in the Highly Active Antiretroviral Therapy Era

3. HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety

4. Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy

5. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry;Journal of Antimicrobial Chemotherapy;2024-07-13

2. Achievement of Primary Prevention Cardiometabolic Targets in Women with HIV: An Urgent Call to Action to Pursue Cardiovascular Health;Viruses;2024-04-09

3. Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study;Open Forum Infectious Diseases;2024-03-18

4. Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV;HIV Medicine;2024-02-20

5. Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?;Healthcare;2024-02-06